...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Month 10
2
Apr 14, 2017 08:49PM
6
Apr 15, 2017 03:16PM
3
Apr 16, 2017 03:49PM
4
Apr 16, 2017 05:19PM
3
Apr 16, 2017 07:16PM
2
Apr 16, 2017 08:15PM

SF - From slide 17 of the June 20, 2016 Quarterly Update there are just 3 patients per cohort unless there are issues which would cause an additional 3 patients to be recruited.

tada 

3
Apr 18, 2017 12:08PM
2
Apr 18, 2017 12:49PM
Share
New Message
Please login to post a reply